Ultragenyx Announces Plans to Build Large-scale Gene Therapy Manufacturing Facility to Support Pipeline of Therapies for Rare Diseases Read more
Termination of Bridge Biotherapeutics’s Collaboration and License Agreement with Boehringer Ingelheim Read more
ImmunityBio’s hAd5 COVID-19 Vaccine Candidate Stimulates Memory T-Cell Recall in Patients Infected with SARS-CoV-2 Read more
Lynparza approved in the EU for the treatment of BRCA- mutated metastatic castration-resistant prostate cancer Read more
TFF Pharmaceuticals and Felix Biotechnology Sign Letter of Intent for a Collaboration, Development and License Agreement Read more